Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
← Research & Industry News
External source

STAT+: Pharmalittle: We're reading about a Novartis gene therapy, faster U.K. drug reviews, and more

Novartis acknowledged seven instances of tumors being found in children who were treated with Zolgensma for spinal muscular atrophy

Published by
STAT
Evidence type
Laboratory

Novartis acknowledged seven instances of tumors being found in children who were treated with Zolgensma for spinal muscular atrophy

This item was selected automatically by our daily literature and news monitor because it matches the topics we follow. Read the full story at STAT.

STAT+: Pharmalittle: We're reading about a Novartis gene therapy, faster U.K. drug reviews, and more | Brilliant Blue Biosciences